Preparation and application of nano-immunological preparation based on porous calcium carbonate
A technology of porous calcium carbonate and immune preparations, which can be applied to medical preparations without active ingredients, medical preparations containing active ingredients, and active ingredients of aluminum/calcium/magnesium, etc., which can solve the failure of tumor immunotherapy and the limited effect of immune response. , the toxicity of immune adjuvants and other problems, to achieve the effect of eliminating small lesions, high immune activation efficiency, and good therapeutic effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Embodiment 1 is based on the preparation of porous calcium carbonate nano-preparation
[0031] (1) Synthesis of porous CaCO by gas diffusion reaction 3 Nanoparticles: 220 mg CaCl 2 ·H 2 O and 8 g NH 4 HCO 3 At the same time, put it in a vacuum drying room, control the temperature at 25 ° C, and keep the whole system in a vacuum environment for 24 hours, the obtained CaCO 3 Nanoparticles were separated by centrifugation at 12000 rpm. Then CaCO in absolute ethanol 3 IDOi is loaded in the channel to get CaCO 3 @IDOi (abbreviated as CaI).
[0032] (2) The above nanoparticles are modified with liposomes. First, 20 mg of CaI in ethanol and 2 mg of DOPA were mixed. Then DPPC, cholesterol and DSPE-PEG were added to the above solution at a ratio of 4:4:2M, the solvent was spin-dried by a rotary evaporator, and the obtained nanoparticles were dissolved in an aqueous solution for further use. Then, the obtained nanoparticles were stirred with 200 mg PEI to prepare CaCO ...
Embodiment 2
[0036] Embodiment 2 mouse modeling experiment
[0037] 2.1 In vivo test
[0038] Select female Balb / c mice as research objects, and make tumor-bearing mouse models by subcutaneously injecting mouse breast cancer cells until the tumor grows to 50mm 3 Start medication. The administration groups were CaIPC (experimental group), LIPC, and normal saline. The tumor-bearing mice were administered intravenously, and the tumor volume and weight were measured every other day during the experimental period. The experimental results show that the CaIPC-treated mice in Example 1 have the slowest tumor growth rate, indicating that the present invention can effectively inhibit tumor growth in the mouse model. On the contrary, the LIPC group showed not very excellent tumor suppressive effect compared with the normal saline group, and this result indicated that only the group treated in the present invention showed the optimal tumor therapeutic effect. Body weight is an important parameter...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com